Disruptive Technologies in Transplantation (Repeat)

Tuesday September 15, 2020 from 08:45 to 10:30

Room: Channel 1

300.3 Reducing risk in drug development through precompetitive collaboration

Inish O'Doherty, United States

Executive Director
C-Path’s Type 1 Diabetes (T1D) and Transplant Therapeutic Consortium (TTC)
Critical Path Institute



© 2024 TTS 2020